4.3 Article

HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)

Shohei Beppu et al.

Summary: The study reveals the pathogenic role of HLA-DQA1*05:03 in the development of Neuromyelitis Optica Spectrum Disorder (NMOSD). Higher cell surface expression levels of HLA-DQA1*05:03 compared to other DQA1 alleles were observed, which strongly depended on the amino acid sequence of the alpha 1 domain. In addition, in silico analysis showed that HLA-DQA1*05:03 preferentially presents immunodominant AQP4 peptides and that the peptide major histocompatibility complexes (pMHCs) are more energetically stable in the presence of HLA-DQA1*05:03 than other HLA-DQA1 alleles.

SCIENTIFIC REPORTS (2022)

Article Clinical Neurology

Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis

Farnaz Sinaei et al.

Summary: This study investigated the role of HLA class II polymorphism in the severity and treatment response of myasthenia gravis patients, with no significant associations found between these loci and disease outcomes. Further research with larger sample sizes in diverse populations is needed to determine the exact contribution of HLA class II alleles to MG prognosis.

JOURNAL OF NEUROMUSCULAR DISEASES (2021)

Article Multidisciplinary Sciences

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

Mitsuru Watanabe et al.

Summary: HLA genotypes are associated with susceptibility and protection against multiple sclerosis, influencing the clinical manifestations, but such correlations are unclear in neuromyelitis optica spectrum disorders.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

CD8+ T cell subpopulations and pro-inflammatory cytokines in neuromyelitis optica spectrum disorder

Ziyan Shi et al.

Summary: The study found that circulating CD8(+) T cell subpopulations were significantly altered in NMOSD and MS patients. Patients treated with immunotherapy showed improvements in CD8(+) T cell subpopulations in NMOSD. Furthermore, NMOSD patients exhibited higher levels of pro-inflammatory cytokines compared to healthy controls and MS patients, but these levels decreased in NMOSD patients receiving immunotherapy.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Clinical Neurology

Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition

Pavan Bhargava et al.

Summary: Leptomeningeal inflammation in multiple sclerosis is associated with poor clinical outcomes and severe cortical pathology. By utilizing ultra-high field MRI in experimental autoimmune encephalomyelitis mouse models, researchers have identified a novel therapeutic approach to target meningeal inflammation.
Article Clinical Neurology

Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease

Lahiru Handunnetthi et al.

Summary: This study aimed to identify disease-relevant genes and explore immunological mechanisms contributing to early and late onset forms of myasthenia gravis. They found distinct immunological pathways linked to early and late onset of the disease, with early onset genes being enriched for regulators of toll-like receptor 4 signaling, and late onset genes being exclusively linked to T-cell regulators CD28 and CTLA4. Additionally, causal genetic variants near the CTLA4 gene were identified, resulting in low expression of CTLA4.

ANNALS OF NEUROLOGY (2021)

Article Clinical Neurology

Neuromyelitis optica in patients with myasthenia gravis: Two case-reports

Sheila Castro-Suarez et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Clinical Neurology

Risk of incident autoimmune diseases in patients with thymectomy

Tzu-Min Lin et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Immunology

Associations between HLA and autoimmune neurological diseases with autoantibodies

Sergio Muniz-Castrillo et al.

AUTOIMMUNITY HIGHLIGHTS (2020)

Editorial Material Clinical Neurology

Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases

Vlad C. Bibic et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Article Neurosciences

HLA-alleles class I and II associated with genetic susceptibility to neuromyelitis optica in Brazilian patients

Claudia Suemi Kamoi Kay et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2019)

Article Immunology

Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis

Jezabel Varade et al.

JOURNAL OF AUTOIMMUNITY (2018)

Article Multidisciplinary Sciences

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica

Karol Estrada et al.

NATURE COMMUNICATIONS (2018)

Article Neurosciences

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen

Lineu Cesar Werneck et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2018)

Review Multidisciplinary Sciences

Thymus involvement in early-onset myasthenia gravis

Melanie A. Cron et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)

Article Urology & Nephrology

HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy

Wei-Bo Le et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Immunology

Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica

Zhen Wang et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Clinical Neurology

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder

Nasrin Asgari et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

Article Neurosciences

Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica

Yongxiang Fan et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)

Article Medicine, General & Internal

Randomized Trial of Thymectomy in Myasthenia Gravis

G. I. Wolfe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Multidisciplinary Sciences

Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4

Sharon A. Sagan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Cardiac & Cardiovascular Systems

Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis

Takeshi Ando et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)

Review Clinical Neurology

Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature

Ryotaro Ikeguchi et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2014)

Article Cardiac & Cardiovascular Systems

Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis

Giovanni Leuzzi et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)

Letter Clinical Neurology

HLA-DRB1*alleles genotyping in chronic inflammatory demyelinating polyneuropathy in Greek patients

Maria C. Anagnostouli et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2014)

Article Clinical Neurology

Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status

Satoshi Yoshimura et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Medicine, General & Internal

Autoimmune Rheumatic Diseases 3 Immunopathogenic mechanisms of systemic autoimmune disease

Marie Wahren-Herlenius et al.

LANCET (2013)

Article Clinical Neurology

Myasthenia gravis and neuromyelitis opica: A causal link

J. Spillane et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2013)

Article Multidisciplinary Sciences

Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population

Angelina H. Maniaol et al.

PLOS ONE (2012)

Article Clinical Neurology

Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population

Yan-chen Xie et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2011)

Article Clinical Neurology

HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica

Marcelo Matiello et al.

MULTIPLE SCLEROSIS JOURNAL (2010)

Article Clinical Neurology

Is neuromyelitis optica associated with human leukocyte antigen?

H. Zephir et al.

MULTIPLE SCLEROSIS JOURNAL (2009)

Review Clinical Neurology

The spectrum of neuromyelitis optica

Dean M. Wingerchuk et al.

LANCET NEUROLOGY (2007)

Article Clinical Neurology

Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy

I Kister et al.

ARCHIVES OF NEUROLOGY (2006)

Review Immunology

MHC class II proteins and disease: a structural perspective

EY Jones et al.

NATURE REVIEWS IMMUNOLOGY (2006)

Article Multidisciplinary Sciences

Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia

C Vandiedonck et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Immunology

Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis

GD Sempowski et al.

JOURNAL OF IMMUNOLOGY (2001)

Article Rheumatology

Systemic scleroderma in Greece:: low mortality and strong linkage with HLA-DRB1☆1104 allele

PG Vlachoyiannopoulos et al.

ANNALS OF THE RHEUMATIC DISEASES (2000)